Advertisement
Advertisement

GNLX

GNLX logo

Genelux Corporation Common Stock

3.11
USD
Sponsored
+0.28
+9.89%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

3.19

+0.08
+2.41%

Genelux Corporation Common Stock Profile

About

Genelux Corporation is a clinical-stage biopharmaceutical company. It focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company's most advanced product candidate, Olvi-Vec, is a proprietary, modified strain of the vaccinia virus, a stable DNA virus. Genelux Corporation is based in WESTLAKE VILLAGE, Calif.

Info & Links

CEO

Thomas Zindrick

Headquarters

2625 Townsgate Road Suite 230
Westlake Village, CA 91361, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.genelux.com

Auditor

Weinberg & Company, P.A.

Share holders

979

Employees

26

Genelux Corporation Common Stock Statistics

Valuation Measures

Market Capitalization2

142.82M

Enterprise Value

133.55M

Enterprise Value/EBITDA(ttm)

-3.87

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

8.44

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-153.29%

Return on Invested Capital(ttm)

-179.17%

Return on Assets(ttm)

-111.57%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-34.54M

Net Income Available to Common(ttm)

-33.58M

Diluted EPS(ttm)

-0.86

Share Statistics

Beta (5Y Monthly)

0.47

52-Week Change

9.12%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

44.84M

Dividend Yield

0.00%

Float4

40.86M

% Held by Insiders

8.80%

% Held by Institutions

37.33%

Balance Sheet

Total Cash(mrq)

26.21M

Total Cash Per Share(mrq)

0.58

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.43%

Quick Ratio(mrq)

2.43%

Book Value Per Share(mrq)

0.31

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.68

Free Cash Flow(ytd)

-26.37M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement